CD34 and nonpapillary renal cell carcinoma: Furthermore, CD34-staining immunohistochemistry was carried out in ccRCC and the result validated that MVD in HM group was higher than that in NM or LM groups (Figures 4B and 4C, student t test, p<0.05).